Engineered phage endolysin eliminates Gardnerella in bacterial vaginosis without damaging the healthy vaginal microbiome
Christine Landlinger, Lenka Tisakova, Vera Oberbauer, Timo Schwebs, Agnieszka Latka, Leen Van Simaey, Mario Vaneechoutte, Alexander Guschin, Sonja Swidsinski, Alexander Swidsinski, Lorenzo Corsini
doi: https://doi.org/10.1101/2020.10.21.20216853
Christine Landlinger
aPhagoMed Biopharma GmbH, Vienna Biocenter, Austria
Lenka Tisakova
aPhagoMed Biopharma GmbH, Vienna Biocenter, Austria
Vera Oberbauer
aPhagoMed Biopharma GmbH, Vienna Biocenter, Austria
Ms.Timo Schwebs
aPhagoMed Biopharma GmbH, Vienna Biocenter, Austria
Mr.Agnieszka Latka
bLaboratory Bacteriology Research, Department of Diagnostic Sciences, Faculty of Medicine & Health Sciences, Ghent University, Flanders, Belgium
Leen Van Simaey
bLaboratory Bacteriology Research, Department of Diagnostic Sciences, Faculty of Medicine & Health Sciences, Ghent University, Flanders, Belgium
Ms.Mario Vaneechoutte
bLaboratory Bacteriology Research, Department of Diagnostic Sciences, Faculty of Medicine & Health Sciences, Ghent University, Flanders, Belgium
Alexander Guschin
cMoscow Scientific and Practical Center of Dermatovenerology and Cosmetology.Moscow, Russia
Sonja Swidsinski
dMDI Limbach Berlin GmbH, Berlin, Germany
Alexander Swidsinski
eMedizinische Klinik, Charité CCM, Humboldt Universität, Berlin, Germany
fInstitute of Molecular Medicine, Sechenov First Moscow State Medical University, Moscow, Russia
Lorenzo Corsini
aPhagoMed Biopharma GmbH, Vienna Biocenter, Austria
Data Availability
All relevant data is disclosed in the manuscript.
Posted October 27, 2020.
Engineered phage endolysin eliminates Gardnerella in bacterial vaginosis without damaging the healthy vaginal microbiome
Christine Landlinger, Lenka Tisakova, Vera Oberbauer, Timo Schwebs, Agnieszka Latka, Leen Van Simaey, Mario Vaneechoutte, Alexander Guschin, Sonja Swidsinski, Alexander Swidsinski, Lorenzo Corsini
medRxiv 2020.10.21.20216853; doi: https://doi.org/10.1101/2020.10.21.20216853
Engineered phage endolysin eliminates Gardnerella in bacterial vaginosis without damaging the healthy vaginal microbiome
Christine Landlinger, Lenka Tisakova, Vera Oberbauer, Timo Schwebs, Agnieszka Latka, Leen Van Simaey, Mario Vaneechoutte, Alexander Guschin, Sonja Swidsinski, Alexander Swidsinski, Lorenzo Corsini
medRxiv 2020.10.21.20216853; doi: https://doi.org/10.1101/2020.10.21.20216853
Subject Area
Subject Areas
- Addiction Medicine (380)
- Allergy and Immunology (697)
- Anesthesia (187)
- Cardiovascular Medicine (2821)
- Dermatology (242)
- Emergency Medicine (425)
- Epidemiology (12513)
- Forensic Medicine (10)
- Gastroenterology (798)
- Genetic and Genomic Medicine (4386)
- Geriatric Medicine (399)
- Health Economics (711)
- Health Informatics (2829)
- Health Policy (1042)
- Hematology (372)
- HIV/AIDS (893)
- Medical Education (412)
- Medical Ethics (113)
- Nephrology (460)
- Neurology (4148)
- Nursing (219)
- Nutrition (614)
- Oncology (2186)
- Ophthalmology (622)
- Orthopedics (253)
- Otolaryngology (316)
- Pain Medicine (263)
- Palliative Medicine (81)
- Pathology (483)
- Pediatrics (1166)
- Primary Care Research (481)
- Public and Global Health (6732)
- Radiology and Imaging (1480)
- Respiratory Medicine (895)
- Rheumatology (429)
- Sports Medicine (361)
- Surgery (469)
- Toxicology (57)
- Transplantation (198)
- Urology (173)